Cell & Gene Therapy
WCG Clinical | Insights
Celebrating 25 Years of IBC Reviews: Pioneering the Past, Shaping the Future
Blog Posts
WCG Clinical | Insights
Eyewash Stations & Gene Transfer Studies: NIH Guidelines Explained
Blog Posts
WCG Clinical | Insights
How Long Should Eyes Be Flushed After Exposure?
Blog Posts
WCG Clinical | Insights
Best Practices for Protecting Non-Participants in Human Gene Transfer Clinical Trials
Blog Posts
WCG Clinical | Insights
Why Biotech Sponsors Need Outside Support: IRB, IBC, DMCs and EACs
Whitepapers
WCG Clinical | Insights
Is special safety equipment required for IBC approval?
Blog Posts
WCG Clinical | Insights
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians
Whitepapers
WCG Clinical | Insights
Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”
Blog Posts
WCG Clinical | Insights
WCG IRB’s Response to COVID-19 in 2020: Supporting the Clinical Trial Industry When It Needed It the Most
Case Studies
WCG Clinical | Insights